Literature DB >> 3968183

Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen.

R A Majack, P Bornstein.   

Abstract

The effect of heparin on the biosynthetic phenotype of rat vascular smooth muscle cells (SMC) was investigated in vitro. Addition of heparin to the culture medium of early passage rat SMC resulted in a marked (3-15-fold) increase of a cell layer-associated Mr 60,000 protein that was sensitive to digestion by purified bacterial collagenase and contained significant amounts of hydroxyproline. Pulse-chase analysis of heparin-treated SMC revealed that the Mr 60,000 collagen was a primary and abundant product of these cells and was not processed extracellularly to a smaller form. The inductive effect of heparin could be mimicked by iota carrageenan or dextran sulfates but not by hyaluronic acid, dermatan sulfate, or chondroitin sulfates. The induction was concentration dependent with a maximal effect observed at a heparin concentration of 10 micrograms/ml. Synthesis of the Mr 60,000 collagen increased 18-24 h after addition of heparin to the cultures. Following induction and subsequent removal of heparin, synthesis of the protein remained maximal for at least 12 h and required 72 h to return to a basal level. These data demonstrate that the biosynthetic phenotype of vascular SMC in vitro can be controlled, at least in part, by heparin and related polyanions and suggest a role for similar molecules endogenous to the vessel wall in the regulation of SMC function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968183      PMCID: PMC2113450          DOI: 10.1083/jcb.100.2.613

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  42 in total

1.  A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture.

Authors:  H Sage; P Pritzl; P Bornstein
Journal:  Biochemistry       Date:  1980-12-09       Impact factor: 3.162

2.  An effect of fibronectin in epidermal growth factor (EGF)-stimulated membrane protein phosphorylation in human carcinoma cells.

Authors:  M Rieber; M S Rieber
Journal:  Exp Cell Res       Date:  1982-04       Impact factor: 3.905

Review 3.  The extracellular matrix and the control of proliferation of vascular endothelial and vascular smooth muscle cells.

Authors:  D Gospodarowicz; I Vlodavsky; N Savion
Journal:  J Supramol Struct       Date:  1980

4.  Minor collagens of chicken hyaline cartilage.

Authors:  C A Reese; R Mayne
Journal:  Biochemistry       Date:  1981-09-15       Impact factor: 3.162

5.  Control of collagen production by human diploid lung fibroblasts.

Authors:  S D Breul; K H Bradley; A J Hance; M P Schafer; R A Berg; R G Crystal
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

6.  What controls smooth muscle phenotype?

Authors:  J H Chamley-Campbell; G R Campbell
Journal:  Atherosclerosis       Date:  1981 Nov-Dec       Impact factor: 5.162

7.  Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies.

Authors:  R L Hoover; R Rosenberg; W Haering; M J Karnovsky
Journal:  Circ Res       Date:  1980-10       Impact factor: 17.367

8.  Stimulation of Ca2+ uptake and protein phosphorylation in tumor cells by fibronectin.

Authors:  A Rephaeli; M Spector; E Racker
Journal:  J Biol Chem       Date:  1981-06-25       Impact factor: 5.157

9.  Response of basal epithelial cell surface and Cytoskeleton to solubilized extracellular matrix molecules.

Authors:  S P Sugrue; E D Hay
Journal:  J Cell Biol       Date:  1981-10       Impact factor: 10.539

10.  Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.

Authors:  J J Castellot; M L Addonizio; R Rosenberg; M J Karnovsky
Journal:  J Cell Biol       Date:  1981-08       Impact factor: 10.539

View more
  19 in total

1.  Undifferentiated F9 embryonal carcinoma cells produce a short-chain collagen molecule.

Authors:  B D Smith; C T Baldwin
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

2.  Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparinlike glycosaminoglycans.

Authors:  J M Person; D H Lovett; G J Raugi
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

3.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

Authors:  R A Majack; S C Cook; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 4.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

5.  Partial characterization of a low molecular weight human collagen that undergoes alternative splicing.

Authors:  T Pihlajaniemi; R Myllylä; J Seyer; M Kurkinen; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells.

Authors:  W A Patton; C A Granzow; L A Getts; S C Thomas; L M Zotter; K A Gunzel; L J Lowe-Krentz
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

7.  Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.

Authors:  L A Pukac; J J Castellot; T C Wright; B L Caleb; M J Karnovsky
Journal:  Cell Regul       Date:  1990-04

8.  Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells.

Authors:  A D Snow; R P Bolender; T N Wight; A W Clowes
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

Review 9.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

10.  Human and sheep growth-plate cartilage type X collagen synthesis and the influence of tissue storage.

Authors:  G J Gibson; K T Francki; J J Hopwood; B K Foster
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.